Table 2 Response Rates (Analysis Population)
From: AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
Response | N = 976 |
|---|---|
ORR [%] | 45.6 |
CR, complete response: n (%) | 22 (2.3) |
PR, partial response: n (%) | 423 (43.3) |
SD, stable disease: n (%) | 287 (29.4) |
PD, progressive disease: n (%) | 99 (10.1) |
Not evaluable: n (%) | 145 (14.9) |
DCR [%] | 75.0 |